Literature DB >> 14635828

Extemporaneous compounding: a return to regulatory limbo?

Susan C Winckler1.   

Abstract

Extemporaneous compounding of medications has been an integral component of the practice of pharmacy and medicine since the practices began. A staple of early medical and pharmacy practice, even today many patients benefit from compounding at some point in their care. Unfortunately, the regulation of the practice has not been so consistent. With a recent decision by the US Supreme Court, compounding regulation is again uncertain. This commentary reviews compounding practice, the history of compounding regulation, and discusses the current regulatory status of the practice.

Entities:  

Mesh:

Year:  2002        PMID: 14635828     DOI: 10.1080/j354v16n04_08

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  2 in total

1.  Prescribing Pattern of Dermatological Compounding in Ethiopia: The Case of ALERT Hospital.

Authors:  Muluken Nigatu Selam; Andualem Ababu; Regasa Bayisa; Mahdi Abdella; Edessa Diriba; Minychel Wale; Tadesse Alemu; Tesfa Marew; Assefa Mulu Baye
Journal:  Integr Pharm Res Pract       Date:  2022-01-06

2.  A Critical Assessment of Extemporaneous Formulations for Proton Pump Inhibitors: The Importance of Proper Vehicle Selection.

Authors:  Ognjenka Rahić; Jasmina Hadžiabdić; Amina Tucak; Merima Sirbubalo; Lamija Hindija; Alisa Elezović; Edina Vranić
Journal:  J Pediatr Pharmacol Ther       Date:  2022-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.